Abbvie Inc
NYSE: ABBV
$177.07
+$0.12 (+0.1%)
Closing Price on November 25, 2024
ABBV Articles
The March 31 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical stocks short interest was mixed.
Published:
Last Updated:
Now all investor eyes turn to first-quarter earnings results. With interest rates still very low, investors looking to add capital should still focus on top dividend-paying stocks.
Published:
Last Updated:
Long-term growth investors looking for a degree of safety and value should consider some of these outstanding companies. While the sentiment may be less than stellar now, massive drug pricing changes...
Published:
Last Updated:
For the most part, Jefferies maintained its list of top companies in the health care sector, but it also made a couple additions and updated its price target information.
Published:
Last Updated:
The February 29 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical stocks short interest decreased.
Published:
Last Updated:
In a recent research report, Jefferiesfocused on some large cap stocks that are still trading way below their 52-week highs.
Published:
Last Updated:
The top analyst upgrades, downgrades and initiations seen from Monday, March 7, include Enbridge, Micron Technology, Sun Life Financial, Starbucks, Stratasys and Wynn Resorts.
Published:
Last Updated:
The top analyst upgrades, downgrades and initiations seen from Friday, February 26, include American Water Works, Autodesk, Kraft Heinz, Palo Alto Networks, Toyota and Vipshop.
Published:
Last Updated:
The February 12 short interest data have been compared with the previous figures, and for the selected pharmaceutical stocks short interest increased.
Published:
Last Updated:
These stocks make good sense for long-term patient investors that have a growth and income total return bias in their portfolios.
Published:
Last Updated:
The top analyst upgrades, downgrades and initiations seen on Tuesday, February 23, include Annaly Capital Management, Barrick Gold, Cheniere Energy, Fitbit, Dean Foods, Groupon, SolarCity, Twitter...
Published:
Last Updated:
In a new research report, Jefferies shuffles some of the pharmaceutical stocks in its coverage universe and a beaten-down dividend leader is now the top pick globally.
Published:
Last Updated:
The top analyst upgrades, downgrades and initiations seen on Monday, February 22, include AbbVie, Deere, Expedia, Hewlett Packard Enterprise, JPMorgan and Phillips 66.
Published:
Last Updated:
For worried investors that need an income stream, all these top stocks make good sense for growth and income portfolios.
Published:
Last Updated:
One thing that the recent sell-off has accomplished is to take top companies residing in the Jefferies Franchise Picks list to levels not seen in some time.
Published:
Last Updated: